Sable Offshore Corp. (SOC)
NYSE: SOC · Real-Time Price · USD
25.91
-0.22 (-0.84%)
At close: Mar 28, 2025, 4:00 PM
25.73
-0.18 (-0.69%)
Pre-market: Mar 31, 2025, 8:53 AM EDT

Company Description

Sable Offshore Corp. operates as an independent oil and gas company in the United States.

The company operates through three platforms located in federal waters offshore California. It also owns and operates 16 federal leases across approximately 76,000 acres, as well as subsea pipelines that transports crude oil, natural gas, and produced water from the platforms to the onshore processing facilities.

The company was formerly known as Flame Acquisition Corp. and changed its name to Sable Offshore Corp. in February 2024.

Sable Offshore Corp. was incorporated in 2020 and is headquartered in Houston, Texas.

Sable Offshore Corp.
Sable Offshore logo
Country United States
Founded 2020
Industry Oil & Gas Drilling
Sector Energy
Employees 161
CEO James Flores

Contact Details

Address:
845 Texas Avenue, Suite 2920
Houston, Texas 77002
United States
Phone 713 579 6161
Website sableoffshore.com

Stock Details

Ticker Symbol SOC
Exchange NYSE
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001831481
CUSIP Number 78574H104
ISIN Number US78574H1041
Employer ID 85-3514078
SIC Code 1311

Key Executives

Name Position
James C. Flores Chairman and Chief Executive Officer
J. Caldwell Flores President
Gregory D. Patrinely Executive Vice President and Chief Financial Officer
Doss R. Bourgeois Executive Vice President and Chief Operating Officer
Harrison Breaud Vice President of Finance and Investor Relations
Anthony C. Duenner Executive Vice President, General Counsel and Secretary

Latest SEC Filings

Date Type Title
Mar 17, 2025 8-K Current Report
Mar 17, 2025 POS EX Filing
Mar 17, 2025 POS EX Filing
Mar 17, 2025 424B3 Prospectus
Mar 17, 2025 424B3 Prospectus
Mar 17, 2025 10-K Annual Report
Feb 19, 2025 424B3 Prospectus
Feb 19, 2025 424B3 Prospectus
Feb 19, 2025 8-K Current Report
Feb 13, 2025 424B3 Prospectus